In January-March 2012, the company posted net profit of RON12.9 million.
Antibiotice reported sales of RON59.4 million in the first quarter of 2013, down 17.5% from RON72 million in the year-ago period.
“Considering the financial deadlock in the domestic market, Antibiotice decided to channel its efforts to increase exports,” the company said in its financial report.
It said exports rose over 40% year-on-year to $6.1 million in the first quarter, from $4.3 million in the same period of 2012.
Antibiotice is majority-owned by Romania’s Health Ministry, with a 53% stake, while investment fund SIF Oltenia (SIF5.RO) holds a 10% stake.
Wednesday, Antibiotice closed up 0.23% at RON0.445 a share in Bucharest, valuing the company at RON252.7 million. (EUR1=RON4.3344)